相似文献
1
Subacute sclerosing panencephalitis (SSPE) in Papua New Guinea: a high incidence in young children.
Epidemiol Infect. 1992 Jun;108(3):547-53. doi: 10.1017/s0950268800050044.
2
A continuing high incidence of subacute sclerosing panencephalitis (SSPE) in the Eastern Highlands of Papua New Guinea.
Epidemiol Infect. 2003 Oct;131(2):887-98. doi: 10.1017/s0950268803008999.
3
Subacute sclerosing panencephalitis in papua new guinean children: the cost of continuing inadequate measles vaccine coverage.
PLoS Negl Trop Dis. 2011 Jan 4;5(1):e932. doi: 10.1371/journal.pntd.0000932.
4
Analysis of serum and cerebrospinal fluid cytokine levels in subacute sclerosing panencephalitis in Papua New Guinea.
Cytokine. 2006 Jan 7;33(1):17-20. doi: 10.1016/j.cyto.2005.11.009. Epub 2006 Jan 18.
5
High incidence of subacute sclerosing panencephalitis (SSPE) in young children in Papua New Guinea.
Med J Aust. 1990;153(11-12):740. doi: 10.5694/j.1326-5377.1990.tb126355.x.
6
Clinical presentation of subacute sclerosing panencephalitis in Papua New Guinea.
Trop Med Int Health. 2003 Mar;8(3):219-27. doi: 10.1046/j.1365-3156.2003.01020.x.
7
[Epidemiology of subacute sclerosing panencephalitis in Okinawa, Japan (1977-2005)].
No To Hattatsu. 2010 Nov;42(6):427-31.
8
Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE).
Neurology. 1983 Dec;33(12):1558-64.
9
High incidence of subacute sclerosing panencephalitis in south India.
Epidemiol Infect. 1990 Feb;104(1):151-6. doi: 10.1017/s0950268800054637.
引用本文的文献
1
Subacute Sclerosing Panencephalitis: Recent Advances in Pathogenesis, Diagnosis, and Treatment.
Ann Indian Acad Neurol. 2025 Mar 1;28(2):159-168. doi: 10.4103/aian.aian_1112_24. Epub 2025 Apr 4.
2
Subacute sclerosing panencephalitis in papua new guinean children: the cost of continuing inadequate measles vaccine coverage.
PLoS Negl Trop Dis. 2011 Jan 4;5(1):e932. doi: 10.1371/journal.pntd.0000932.
本文引用的文献
1
Risk factors in subacute sclerosing panencephalitis: a case-control study.
Am J Epidemiol. 1980 Apr;111(4):415-24. doi: 10.1093/oxfordjournals.aje.a112916.
2
Persistent measles infection of the central nervous system: subacute sclerosing panencephalitis.
Rev Infect Dis. 1983 May-Jun;5(3):467-73. doi: 10.1093/clinids/5.3.467.
3
Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE).
Neurology. 1983 Dec;33(12):1558-64.
4
Subacute sclerosing panencephalitis (SSPE): a report of 16 cases.
Aust N Z J Med. 1984 Apr;14(2):126-30. doi: 10.1111/j.1445-5994.1984.tb04274.x.
5
Partial C4 deficiency in subacute sclerosing panencephalitis.
Immunogenetics. 1984;20(4):407-15. doi: 10.1007/BF00345615.
6
Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex.
Ann Neurol. 1982 Apr;11(4):359-64. doi: 10.1002/ana.410110407.
7
Subacute sclerosing panencephalitis. A multidisciplinary study of eight cases.
JAMA. 1969 Mar 24;207(12):2248-54. doi: 10.1001/jama.207.12.2248.
8
Epidemiology of subacute sclerosing panencephalitis (SSPE). A report of the SSPE registry.
JAMA. 1972 May 15;220(7):959-62.
9
Production of antibody by the central nervous system in subacute sclerosing panencephalitis.
Neurology. 1968 Jan;18(1 Pt 2):129-32. doi: 10.1212/wnl.18.1_part_2.129.
10
Enzyme immunoassay versus plaque neutralization and other methods for determination of immune status to measles and varicella-zoster viruses and versus complement fixation for serodiagnosis of infections with those viruses.
J Clin Microbiol. 1985 Jun;21(6):869-74. doi: 10.1128/jcm.21.6.869-874.1985.
Zotero 插件